Unlocking the Secrets of the Brain: New Study Reveals Progress, but Challenges Remain in Using Neuroimaging to Diagn PTSD

A recent study led by Yale researchers has shown that while neuroimaging technology holds great promise in linking specific symptoms of mental health disorders to abnormal patterns of brain activity, there are still significant obstacles to overcome before doctors can accurately diagnose conditions like post-traumatic stress disorder (PTSD) using brain scans. The National Institutes of Mental Health has invested billions of dollars in recent years to find biomarkers of brain activity that point to the biological roots of mental health diseases, however, the Yale study suggests that more research is needed to develop reliable models that can be generalized across different studies and populations. Despite these challenges, the researchers are optimistic that with further study, neuroimaging technology will one day be a powerful tool in the diagnosis and treatment of PTSD and other mental health disorders.

Discussion Questions:

Take a look at the study and answer the following discussion questions

Ben-Zion, Z., Spiller, T. R., Keynan, J. N., Admon, R., Levy, I., Liberzon, I., ... & Harpaz-Rotem, I. (2023). Evaluating the Evidence for Brain-Based Biotypes of Psychiatric Vulnerability in the Acute Aftermath of Trauma. American Journal of Psychiatry, appi-ajp.

  1. What is the goal of using neuroimaging technology in the diagnosis of mental health disorders?

  2. How does the study led by Yale researchers suggest that there are still kinks to be ironed out in using brain imaging for PTSD diagnosis?

  3. What is the current state of using biomarkers to refine psychiatric diagnoses?

  4. How are the Yale researchers working to further develop reliable models for using brain imaging in PTSD diagnosis?

For more about psychological disorders take a look at Carter, K. (2022). Psychopathology: Understanding Psychological Disorders. Cambridge University Press.

www.cambridge.org/psychopathology

Dr. Ken Carter
Dr. Kenneth Carter received his Ph.D. in Clinical Psychology from the University of Michigan, Ann Arbor in 1993 and in 2007 finished a postdoctoral masters in clinical psychopharmacology from Farleigh Dickenson University. Before joining the faculty at Emory University, Dr. Carter served as a Senior Assistant Research Scientist in the Epidemic Intelligence Service of the Centers for Disease Control and Prevention where he researched smoking as a risk marker for suicidal behaviors in adolescents. Currently he is an Associate Professor of Psychology at Oxford College of Emory University where he is actively involved in research and teaching. Dr. Carter has been a psychotherapist and researcher for over 17 years and his work has garnered awards from the National Institutes of Health, the National Heart, Lung and Blood Institute, and the University of Michigan. In addition to research, Dr. Carter’s is actively engaged in translating research in psychology to everyday language. He has appeared in magazines such as mental_floss and Readers Digest, and well as in news programs such as Connect With Kids and NBC’s Today Show.
www.drkencarter.com
Previous
Previous

Healing and Empowerment in the Face of Racial Trauma: An Interview with Dr. Handford

Next
Next

Exploring the Long-term Impact of SSRIs on Reinforcement Learning: Insights from the Escitalopram Study